Two Sigma Investments, LP Matinas Bio Pharma Holdings, Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.67 - $1.51 $17,574 - $39,608	-26,231 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$0.75 - $1.1 $19,673 - $28,854	26,231 New	26,231 $20,000
Q1 2021 May 17, 2021	SELL	$0.96 - $1.74 $91,918 - $166,601	-95,748 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$0.76 - $1.47 $1.04 Million - $2.02 Million	-1,373,295 Reduced 93.48%	95,748 $130,000
Q3 2020 Nov 16, 2020	BUY	$0.67 - $0.96 $124,979 - $179,075	186,537 Added 14.54%	1,469,043 $1.13 Million
Q2 2020 Aug 14, 2020	BUY	$0.52 - $0.92 $316,815 - $560,520	609,261 Added 90.5%	1,282,506 $991,000
Q1 2020 May 15, 2020	BUY	$0.6 - $2.31 $403,947 - $1.56 Million	673,245 New	673,245 $404,000
Q4 2019 Feb 14, 2020	SELL	$0.63 - $2.27 $7,100 - $25,582	-11,270 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.59 - $0.9 $6,649 - $10,143	11,270 New	11,270 $7,000

3.66M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $137M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.